← Back to Search
Atopic Dermatitis: Global Epidemiology And Risk Factors
Published 2015 · Medicine
Download PDFAnalyze on Scholarcy
Atopic dermatitis (AD) is a chronic inflammatory skin disease posing a significant burden on health-care resources and patients' quality of life. It is a complex disease with a wide spectrum of clinical presentations and combinations of symptoms. AD affects up to 20% of children and up to 3% of adults; recent data show that its prevalence is still increasing, especially in low-income countries. First manifestations of AD usually appear early in life and often precede other allergic diseases such as asthma or allergic rhinitis. Individuals affected by AD usually have genetically determined risk factors affecting the skin barrier function or the immune system. However, genetic mutations alone might not be enough to cause clinical manifestations of AD, and it is merely the interaction of a dysfunctional epidermal barrier in genetically predisposed individuals with harmful effects of environmental agents which leads to the development of the disease. AD has been described as an allergic skin disease, but today, the contribution of allergic reactions to the initiation of AD is challenged, and it is proposed that allergy is rather a consequence of AD in subjects with a concomitant underlying atopic constitution. Treatment at best achieves symptom control rather than cure; there is thus a strong need to identify alternatives for disease prevention.
This paper references
Allergy development and the intestinal microflora during the first year of life.
B. Björkstén (2001)
Atopic Dermatitis and the ‘Hygiene Hypothesis’: Too Clean to Be True?
B. Thiers (2006)
Role of Bacterial Superantigens in Atopic Dermatitis
I. Cardona (2006)
Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three.
J. Odhiambo (2009)
Quality of life and childhood atopic dermatitis: the misery of living with childhood eczema
S. Lewis-Jones (2006)
Atopic dermatitis and the hygiene hypothesis revisited.
C. Flohr (2011)
Recent perspectives on the global epidemiology of childhood eczema.
C. Flohr (2011)
The Socioeconomic Impact of Atopic Dermatitis in the United States: A Systematic Review
A. Mancini (2008)
New insights into the allergic march
M. Shaker (2014)
Clinical Use of Probiotics in Pediatric Allergy (cuppa): A World Allergy Organization Position Paper
A. Fiocchi (2012)
New approaches to the prevention of childhood atopic dermatitis
C. Flohr (2014)
Partially Hydrolyzed 100% Whey Protein Infant Formula and Reduced Risk of Atopic Dermatitis: A Meta-analysis
D. Alexander (2010)
Atopic dermatitis in a population based twin series. Concordance rates and heritability estimation.
F. Schultz Larsen (1985)
Timing of Solid Food Introduction in Relation to Eczema, Asthma, Allergic Rhinitis, and Food and Inhalant Sensitization at the Age of 6 Years: Results From the Prospective Birth Cohort Study LISA
A. Zutavern (2008)
Allergies in high-risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10-year results from the German Infant Nutritional Intervention (GINI) study.
A. von Berg (2013)
Maternal fish intake during pregnancy and atopy and asthma in infancy
I. Romieu (2007)
Endogenous antimicrobial peptides and skin infections in atopic dermatitis.
P. Ong (2002)
Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys
M. Asher (2006)
Farm exposure in utero may protect against asthma, hay fever and eczema
J. Douwes (2008)
Farm environment in childhood prevents the development of allergies
Atopic dermatitis and the atopic march revisited
S. Dharmage (2014)
Prebiotics in infants for prevention of allergy.
D. Osborn (2013)
Austrian children living on a farm have less hay fever, asthma and allergic sensitization
Early exposure to solid foods and the development of eczema in children up to 4 years of age
M. Sariachvili (2010)
Childhood atopic eczema
R. S. Barnetson (2002)
International Study of Asthma and Allergies in Childhood (ISAAC)
A. Shah (1994)
Reduced diversity in the early fecal microbiota of infants with atopic eczema.
M. Wang (2008)
Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing.
M. Kalliomäki (2001)
Loss-of-function variants in the filaggrin gene are a significant risk factor for peanut allergy
S. Brown (2011)
Lack of evidence for a protective effect of prolonged breastfeeding on childhood eczema: lessons from the International Study of Asthma and Allergies in Childhood (ISAAC) Phase Two
C. Flohr (2011)
Food allergy and atopic dermatitis: separating fact from fiction.
Ki-Young Suh (2010)
Differences in fecal microflora between patients with atopic dermatitis and healthy control subjects.
S. Watanabe (2003)
The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double-blind trial.
A. von Berg (2003)
Pet exposure and risk of atopic dermatitis at the pediatric age: a meta-analysis of birth cohort studies.
C. Pelucchi (2013)
SPINK5: A gene for atopic dermatitis and asthma
M. Moffatt (2004)
Prevalence of hay fever and allergic sensitization in farmer's children and their peers living in the same rural community
The cost of atopic dermatitis in the Netherlands: an international comparison
P. Verboom (2002)
Prevalence of IgE-Mediated Food Allergy Among Children With Atopic Dermatitis
P. Eigenmann (1998)
Dietary supplements for established atopic eczema.
F. Bath-Hextall (2012)
Trends in asthma, allergic rhinitis and eczema among Swedish conscripts from farming and non‐farming environments. A nationwide study over three decades
L. Bråbäck (2004)
Solid food introduction in relation to eczema: results from a four-year prospective birth cohort study.
B. Filipiak (2007)
An update on the genetics of atopic dermatitis: scratching the surface in 2009.
K. Barnes (2010)
Itch intensity evaluated in the German Atopic Dermatitis Intervention Study (GADIS): correlations with quality of life, coping behaviour and SCORAD severity in 823 children.
E. Weisshaar (2008)
Immunopathology of atopic dermatitis
D. Leung (2004)
Pre‐ and post‐natal exposure to antibiotics and the development of eczema, recurrent wheezing and atopic sensitization in children up to the age of 4 years
S. Dom (2010)
Early introduction of fish decreases the risk of eczema in infants
G. Kim (2010)
Does early life exposure to antibiotics increase the risk of eczema? A systematic review
T. Tsakok (2013)
Preventive effect of hydrolyzed infant formulas persists until age 6 years: long-term results from the German Infant Nutritional Intervention Study (GINI).
A. von Berg (2008)
The Burden of Atopic Dermatitis: Impact on the Patient, Family, and Society
C. Carroll (2005)
The intestinal microflora in allergic Estonian and Swedish 2‐year‐old children
The International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three: a global synthesis.
J. Mallol (2013)
New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions.
M. Cork (2006)
Compartmentalized Control of Skin Immunity by Resident Commensals
Shruti Naik (2012)
DY: Role of bacterial superantigens in atopic dermatitis: implications for future therapeutic strategies
ID Cardona (2006)
Cost of Illness of Atopic Dermatitis in Children
A. Kemp (2012)
Meta-analysis of the evidence for a partially hydrolyzed 100% whey formula for the prevention of allergic diseases
H. Szajewska (2010)
Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis
C. Palmer (2006)
The role of furry pets in eczema: a systematic review.
S. Langan (2007)
Probiotics Supplementation During Pregnancy or Infancy for the Prevention of Atopic Dermatitis: A Meta-analysis
C. Pelucchi (2012)
Age at First Introduction of Cow Milk Products and Other Food Products in Relation to Infant Atopic Manifestations in the First 2 Years of Life: The KOALA Birth Cohort Study
Jaime P Olenec (2009)
Development of atopic dermatitis according to age of onset and association with early-life exposures.
C. Roduit (2012)
Maternal farm exposure/ingestion of unpasteurized cow's milk and allergic disease
E. von Mutius (2012)
Do early intake of fish and fish oil protect against eczema and doctor-diagnosed asthma at 2 years of age? A cohort study
T. Øien (2009)
Innate immune defects in atopic dermatitis.
L. Y. McGirt (2006)
Assessment of outcomes and parental effect on Quality-of-Life endpoints in the management of atopic dermatitis.
R. Arnold (2007)
From atopic dermatitis to asthma: the atopic march.
J. Spergel (2010)
This paper is referenced by
The Pathogenesis of Atopic Dermatitis: The Role of Filaggrin
Tamarachiara Kuntjoro (2017)
The Burden of Moderate to Severe Atopic Dermatitis in Canadian Children: A Cross-Sectional Survey
Alanna C Bridgman (2018)
Estimation of IgE level and Rh factor in patients with atopic dermatitis
Eman Wahab Kadhum (2019)
Kinetic‐Pharmacodynamic Model of Platelet Time Course in Patients With Moderate‐to‐Severe Atopic Dermatitis Treated With Oral Janus Kinase 1 Inhibitor Abrocitinib
E. Soto (2020)
Extrinsic Factors Shaping the Skin Microbiome
Veronica Moskovicz (2020)
Dysbiosis of the Skin Microbiome in Atopic Dermatitis
J. Cheng (2020)
The skin microbiome: impact of modern environments on skin ecology, barrier integrity, and systemic immune programming
S. Prescott (2017)
A systematic review and meta-analysis of the prevalence and phenotype of adult-onset atopic dermatitis.
Harrison H Lee (2019)
Efektivitas Lactobacillus plantarum terhadap Serum Imunoglobulin E Total dan Indeks Scoring Atopic Dermatitis (SCORAD) Pasien Dermatitis Atopik Dewasa
L. Bonita (2019)
Altered Epidermal Permeability Barrier Function in the Uninvolved Skin Supports a Role of Epidermal Dysfunction in the Pathogenesis of Occupational Hand Eczema
Xiaohua Wang (2020)
Age Related Clinical Spectrum of Atopic Dermatitis: A Position Paper
Virendra N Sehgal (2018)
The Role of Elimination Diets in Atopic Dermatitis—A Comprehensive Review
Neil R Lim (2017)
Estimated prevalence of smallpox vaccine contraindications in Israeli adolescents.
I. Fogel (2016)
MicroRNA Cross-Involvement in Autism Spectrum Disorders and Atopic Dermatitis: A Literature Review
A. Tonacci (2019)
Efficacy and Safety of Socheongryong-Tang Among Atopic Dermatitis Patients With Respiratory Disorders: A Double-Blinded, Randomized, Placebo-Controlled Clinical Trial
J. H. Lee (2020)
Simple Markers for Systemic Inflammation in Pediatric Atopic Dermatitis Patients
S. B. Batmaz (2018)
Identification of novel candidate variants including COL6A6 polymorphisms in early-onset atopic dermatitis using whole-exome sequencing
W. Heo (2017)
The indirect costs of allergic diseases.
J. Stróżek (2019)
Narrowband UV-B phototherapy in childhood atopic dermatitis: efficacy and safety*
S. Dayal (2017)
Burden and socioeconomics of asthma, allergic rhinitis, atopic dermatitis and food allergy
Boudewijn J H Dierick (2020)
Staphylococcus aureus wall teichoic acid is a pathogen-associated molecular pattern that is recognized by langerin (CD207) on skin Langerhans cells
R. V. Dalen (2017)
Metabolic Syndrome and Skin Diseases
Yu Hu (2019)
Prevalence and Comorbidity of Atopic Dermatitis in Children: A Large-Scale Population Study Based on Real-World Data
Y. Gilaberte (2020)
Baricitinib: therapeutic potential for moderate to severe atopic dermatitis
Laura Calabrese (2020)
Who Sees you Matters: A Population Study Examining Topical Corticosteroid Prescribing Patterns between Primary Care Providers and Dermatologists for Atopic Dermatitis.
I. Singh (2020)
Effectiveness of Emollient Therapy in Pediatric Patients With Atopic Dermatitis
Amanda Barfield (2017)
Treatment Patterns of Pediatric Patients with Atopic Dermatitis: A Claims Data Analysis.
A. Paller (2019)
Clinical Applications of System Regulation Medicine
M. Fioranelli (2019)
Burden of atopic dermatitis in Asia
T. Tsai (2019)
Atopic Dermatitis Much More Than Skin Disease
L. Ahmetaj (2020)
Pyrus ussuriensis Maxim. leaves extract ameliorates DNCB-induced atopic dermatitis-like symptoms in NC/Nga mice.
Kyohee Cho (2018)
Caffeine in the Treatment of Atopic Dermatitis and Psoriasis: A Review
Mais Bassam Alashqar (2019)See more